Asston Pharmaceuticals
add_icon

Asston Pharmaceuticals

75.00
-3.00
(-3.85%)
Market Cap
63.85 Cr
PE Ratio
-
Volume
8,000.00
Day High - Low
76.00 - 70.26
52W High-Low
126.00 - 75.21
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
63.85 Cr
EPS
6.14
PE Ratio
-
PB Ratio
-
Book Value
45.35
EBITDA
6.00
Dividend Yield
0.00 %
Return on Equity
34.91
Debt to Equity
0.77
Forecast For
Actual

Company News

View All News
Caret
neutral
Asston Pharmaceuticals Limited has appointed M/s Panchal S K and Associates as statutory auditors following board approval on February 27, 2026, subject to shareholder approval at the upcoming general meeting.
neutral
Asston Pharmaceuticals Limited announces resignation of statutory auditor M/s. Doshi Doshi & Co due to preoccupation with other assignments, effective January 28, 2026.
positive
Asston Pharmaceuticals Limited commenced commercial production at its Unit II facility in Maharashtra on January 21, 2026, manufacturing pharmaceuticals and nutraceuticals products as per scheduled plan.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
2,726.60
#1 78,428.17
23.16
14,846.10
27.62
#1 1,928
118.35
45.48
8,989.00
36,107.30
39.01
#1 18,680.60
15.07
821
19.44
40.19
781.85
35,417.36
26.86
6,652.10
109.76
937
53.45
56.95
200.26
13,864.90
16.03
2,360.30
147.31
369
165.73
48.74
246.40
7,493.31
14.32
2,524.60
98.10
295
147.27
40.41
181.31
6,569.41
14.93
3,459.50
37.06
140
#1 416.84
43.62
879.20
5,867.26
63.40
1,115.20
26.44
63
35.83
36.07
352.20
4,476.64
#1 11.73
2,192.50
99.83
214
143.70
39.41
3,727.40
4,264.22
23.69
639.60
56.11
147
21.55
47.28
1,762.60
3,581.45
22.83
998.10
#1 158.71
159
-
40.54
Growth Rate
Revenue Growth
62.03 %
Net Income Growth
178.57 %
Cash Flow Change
99.24 %
ROE
64.05 %
ROCE
32.28 %
EBITDA Margin (Avg.)
32.64 %

Yearly Financial Results

Annual Financials
2022
2023
2024
2025
TTM
Revenue
11
7
16
26
0
Expenses
10
5
13
20
0
EBITDA
1
2
3
6
0
Operating Profit %
-4 %
23 %
16 %
22 %
0 %
Depreciation
0
0
0
0
0
Interest
0
1
1
1
0
Profit Before Tax
0
1
2
5
0
Tax
0
0
1
1
0
Net Profit
0
1
1
4
0
EPS in ₹
11.62
1.89
2.37
6.14
0.00

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
10
14
20
28
Fixed Assets
1
1
1
1
Current Assets
7
11
18
27
Capital Work in Progress
0
0
0
0
Investments
0
0
0
0
Other Assets
9
13
19
27
Total Equity & Liabilities
10
14
20
28
Current Liabilities
8
10
12
15
Non Current Liabilities
1
2
2
2
Total Equity
1
2
6
11
Reserve & Surplus
0
1
6
5
Share Capital
1
1
1
6

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
0
0
-0
0
Investing Activities
0
-1
0
1
Operating Activities
-1
-0
-4
0
Financing Activities
1
1
4
-1

Share Holding

% Holding
Jan 2025
Jun 2025
Jul 2025
Sept 2025
Promoter
69.07 %
50.66 %
68.76 %
50.66 %
FIIs
0.00 %
9.70 %
0.00 %
6.04 %
DIIs
0.00 %
4.08 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
30.95 %
0.00 %
37.06 %
Others
30.93 %
4.61 %
31.24 %
6.24 %
No of Share Holders
104
662
128
751

Announcements

Announcement under Regulation 30 (LODR)-Change in ManagementMar 02, 2026
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sMar 02, 2026
Cancellation of Board MeetingFeb 07, 2026
Closure of Trading WindowJan 30, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJan 29, 2026
Announcement under Regulation 30 (LODR)-Resignation of Statutory AuditorsJan 29, 2026
Board Meeting Intimation for Increasing Of Authorised Capital And Raising Of FundsJan 29, 2026
Commencement Of Commercial ProductionJan 21, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Announcement under Regulation 30 (LODR)-Meeting UpdatesJan 05, 2026
Board Meeting Outcome for Outcome Of The Board MeetingJan 05, 2026
Board Meeting Intimation for Considering Loan Facility From HDFC Bank Ltd.Jan 02, 2026
Regulation 30 SEBI (LODR) Regulation Update.Nov 14, 2025
Unaudited Financial Results For The Half Year Ended 30Th September 2025 Along With A Limited Review ReportNov 14, 2025
Board Meeting Outcome for Outcome Of Board MeetingNov 14, 2025
Board Meeting Intimation for Intimation Of Board MeetingNov 11, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 17, 2025
General AnnouncementOct 16, 2025
Meeting UpdatesOct 16, 2025
Appointment of Company Secretary and Compliance OfficerOct 16, 2025
Board Meeting Outcome for Outcome Of Board Meeting Scheduled To Be Held On 16Th October 2025Oct 16, 2025
Board Meeting Intimation for Intimitation Of Board Meeting Schedule To Be Held On 16Th October 2025Oct 13, 2025
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Oct 13, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerOct 13, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesOct 01, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2025
Closure of Trading WindowSep 30, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 08, 2025
Reg. 34 (1) Annual Report.Sep 06, 2025
NOTICE AND INTIMATION OF 6TH AGM SCHEDULED ON 29 SEPTEMBER 2025Sep 06, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderSep 02, 2025
Pursuant To The Provisions Of Regulation 42 Of SEBI (Listing Obligation And Disclosure Requirement) Regulation 2015Aug 25, 2025
Board Meeting Outcome for OUTCOME OF THE BOARD MEETING HELD TODAY I.E. MONDAY AUGUST 25 2025Aug 25, 2025
Board Meeting Intimation for Regulation 29 Of The SEBI (Listing Obligation And Disclosure Requirement) Regulations 2015.Aug 21, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderJul 31, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderJul 23, 2025
Listing of Equity Shares of Asston Pharmaceuticals LtdJul 16, 2025

Technical Indicators

RSI(14)
Neutral
39.98
ATR(14)
Volatile
3.98
STOCH(9,6)
Neutral
42.25
STOCH RSI(14)
Neutral
32.59
MACD(12,26)
Bearish
-0.34
ADX(14)
Weak Trend
20.93
UO(9)
Bearish
54.13
ROC(12)
Downtrend And Accelerating
-8.54
WillR(14)
Neutral
-67.84